Pharmaceutical firms all-out to boost OTC sales

Local drug makers have seen robust growth in earnings for the past couple of years on strong demand for ethical drugs. However, they are finding it increasingly difficult to boost their bottom line amid prolonged business recession and a stiffer competition.

Zuellig Pharma Korea has seen the sales of original drugs fall sharply in recent months. Now, its August sales target is estimated to f...